Can we design a better anti-cytokine therapy?

被引:19
作者
Drutskaya, Marina S. [1 ,2 ]
Efimov, Grigory A. [1 ,3 ]
Kruglov, Andrei A. [1 ,2 ,4 ]
Nedospasov, Sergei A. [1 ,2 ,4 ]
机构
[1] Russian Acad Sci, Engelhardt Inst Mol Biol, Vavilov St 32, Moscow 119991, Russia
[2] Lomonosov Moscow State Univ, Moscow, Russia
[3] Natl Res Ctr Hematol, Moscow, Russia
[4] German Rheumatism Res Ctr DRFZ, Berlin, Germany
基金
俄罗斯科学基金会;
关键词
TNF; IL-6; MYSTI; trans-signaling; damaged cartilage; TUMOR-NECROSIS-FACTOR; EXPERIMENTAL INFLAMMATORY ARTHRITIS; TYPE-1; MATRIX-METALLOPROTEINASE; HUMAN RHEUMATOID-ARTHRITIS; DENDRITIC CELL NETWORKS; FACTOR-RECEPTOR; TNF-ALPHA; T-CELLS; PROINFLAMMATORY CYTOKINE; FACTOR INHIBITOR;
D O I
10.1189/jlb.3MA0117-025R
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cytokine neutralization is successfully used for treatment of various autoimmune diseases and chronic inflammatory conditions. The complex biology of the two well-characterized proinflammatory cytokines TNF and IL-6 implicates unavoidable consequences when it comes to their global blockade. Because systemic cytokine ablation may result in unwanted side effects, efforts have been made to develop more specific cytokine inhibitors, which would spare the protective immunoregulatory functions of a given cytokine. In this article, we review current research and summarize new strategies for improved anti-TNF and anti-IL-6 biologics, which specifically target only selected parts of the signaling cascades mediated by these ligands.
引用
收藏
页码:783 / 790
页数:8
相关论文
共 92 条
[1]   Prominent role for T cell-derived Tumour Necrosis Factor for sustained control of Mycobacterium tuberculosis infection [J].
Allie, Nasiema ;
Grivennikov, Sergei I. ;
Keeton, Roanne ;
Hsu, Nai-Jen ;
Bourigault, Marie-Laure ;
Court, Nathalie ;
Fremond, Cecile ;
Yeremeev, Vladimir ;
Shebzukhov, Yuriy ;
Ryffel, Bernhard ;
Nedospasov, Sergei A. ;
Quesniaux, Valerie F. J. ;
Jacobs, Muazzam .
SCIENTIFIC REPORTS, 2013, 3
[2]   TnF neutralization results in the Delay of Transplantable Tumor growth and reduced MDsc accumulation [J].
Atretkhany, Kamar-Sulu N. ;
Nosenko, Maxim A. ;
Gogoleva, Violetta S. ;
Zvartsev, Ruslan V. ;
Qin, Zhihai ;
Nedospasov, Sergei A. ;
Drutskaya, Marina S. .
FRONTIERS IN IMMUNOLOGY, 2016, 7
[3]   Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation:: Evidence in Crohn disease and experimental colitis in vivo [J].
Atreya, R ;
Mudter, J ;
Finotto, S ;
Müllberg, J ;
Jostock, T ;
Wirtz, S ;
Schütz, M ;
Bartsch, B ;
Holtmann, M ;
Becker, C ;
Strand, D ;
Czaja, J ;
Schlaak, JF ;
Lehr, HA ;
Autschbach, F ;
Schürmann, G ;
Nishimoto, N ;
Yoshizaki, K ;
Ito, H ;
Kishimoto, T ;
Galle, PR ;
Rose-John, S ;
Neurath, MF .
NATURE MEDICINE, 2000, 6 (05) :583-588
[4]   Bispecific T-Cell Engaging Antibodies for Cancer Therapy [J].
Baeuerle, Patrick A. ;
Reinhardt, Carsten .
CANCER RESEARCH, 2009, 69 (12) :4941-4944
[5]   Selective blockade of interleukin-6 trans-signaling improves survival in a murine polymicrobial sepsis model [J].
Barkhausen, Tanja ;
Tschernig, Thomas ;
Rosenstiel, Philip ;
van Griensven, Martijn ;
Vonberg, Ralf-Peter ;
Dorsch, Martina ;
Mueller-Heine, Annika ;
Chalaris, Athena ;
Scheller, Juergen ;
Rose-John, Stefan ;
Seegert, Dirk ;
Krettek, Christian ;
Waetzig, Georg H. .
CRITICAL CARE MEDICINE, 2011, 39 (06) :1407-1413
[6]   Inflammation-induced formation of fat-associated lymphoid clusters [J].
Benezech, Cecile ;
Luu, Nguyet-Thin ;
Walker, Jennifer A. ;
Kruglov, Andrei A. ;
Loo, Yunhua ;
Nakamura, Kyoko ;
Zhang, Yang ;
Nayar, Saba ;
Jones, Lucy H. ;
Flores-Langarica, Adriana ;
McIntosh, Alistair ;
Marshall, Jennifer ;
Barone, Francesca ;
Besra, Gurdyal ;
Miles, Katherine ;
Allen, Judith E. ;
Gray, Mohini ;
Kollias, George ;
Cunningham, Adam F. ;
Withers, David R. ;
Toellner, Kai Michael ;
Jones, Nick D. ;
Veldhoen, Marc ;
Nedospasov, Sergei A. ;
McKenzie, Andrew N. J. ;
Caamano, Jorge H. .
NATURE IMMUNOLOGY, 2015, 16 (08) :819-+
[7]   A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells [J].
Black, RA ;
Rauch, CT ;
Kozlosky, CJ ;
Peschon, JJ ;
Slack, JL ;
Wolfson, MF ;
Castner, BJ ;
Stocking, KL ;
Reddy, P ;
Srinivasan, S ;
Nelson, N ;
Boiani, N ;
Schooley, KA ;
Gerhart, M ;
Davis, R ;
Fitzner, JN ;
Johnson, RS ;
Paxton, RJ ;
March, CJ ;
Cerretti, DP .
NATURE, 1997, 385 (6618) :729-733
[8]   Interleukin-6 Trans-Signaling and Colonic Cancer Associated with Inflammatory Bowel Disease [J].
Chalaris, Athena ;
Schmidt-Arras, Dirk ;
Yamamoto, Kosuke ;
Rose-John, Stefan .
DIGESTIVE DISEASES, 2012, 30 (05) :492-499
[9]   TNFR2 Is Critical for the Stabilization of the CD4+Foxp3+ Regulatory T Cell Phenotype in the Inflammatory Environment [J].
Chen, Xin ;
Wu, Xueqiang ;
Zhou, Qiong ;
Howard, O. M. Zack ;
Netea, Mihai G. ;
Oppenheim, Joost J. .
JOURNAL OF IMMUNOLOGY, 2013, 190 (03) :1076-1084
[10]  
Chen XY, 2016, SCI REP, V6.